MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer.

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-23-3748
Affiliations:
4
Authors:
9
Go to article
Institutions Authors Share
Nanjing Medical University (NJMU), China
5.000000
 0.56
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China
4.000000
 0.44
Interested in Oncology and Carcinogenesis?